Moa levothyroxine
Pro Research Analysisby 
Searched over 200M research papers for "moa levothyroxine"
Mechanism of Action (MOA) of Levothyroxine
Introduction to Levothyroxine
Levothyroxine, also known as L-thyroxine or L-T4, is a synthetic form of the thyroid hormone thyroxine. It is primarily used to treat hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormone. Understanding the mechanism of action (MOA) of levothyroxine is crucial for optimizing its therapeutic efficacy and managing potential interactions with other substances.
Mechanism of Action of Levothyroxine
Levothyroxine works by mimicking the natural thyroid hormone thyroxine (T4) produced by the thyroid gland. Once administered, levothyroxine is absorbed into the bloodstream and converted into triiodothyronine (T3) in peripheral tissues. T3 is the active form of the hormone that binds to thyroid hormone receptors in the nucleus of cells, influencing the transcription of various genes involved in metabolism, growth, and development 12.
Factors Affecting Levothyroxine Bioavailability
Drug Interactions
Several medications can interfere with the bioavailability of levothyroxine. These include calcium and iron supplements, proton pump inhibitors, bile acid sequestrants, phosphate binders, sex hormones, and anticonvulsants. These drugs can reduce the absorption of levothyroxine through mechanisms such as direct complexing, alkalization, alteration of serum thyroxine-binding globulin levels, and acceleration of levothyroxine catabolism via deiodination .
Food and Beverage Interactions
Certain foods and beverages can also impact the absorption of levothyroxine. For instance, coffee, soy products, fiber, and enteral nutrition have been shown to decrease levothyroxine absorption. Additionally, milk, juices, papaya, aluminum-containing preparations, and chromium supplements can alter the drug's efficacy. Conversely, vitamin C has been observed to enhance levothyroxine absorption .
Strategies to Mitigate Interactions
Timing of Administration
Administering levothyroxine at specific times can help mitigate interactions. Studies have shown that taking levothyroxine either in the morning or at bedtime can be equally effective. However, maintaining a proper time interval between levothyroxine and food intake, especially for coffee, calcium, or iron supplements, is crucial to avoid malabsorption .
Alternative Formulations
Novel formulations of levothyroxine, such as liquid solutions and soft-gel capsules, have been developed to address issues related to chelation and alkalization. These formulations can help eliminate malabsorption caused by certain foods and medications .
Conclusion
Levothyroxine is a vital medication for managing hypothyroidism, but its efficacy can be significantly influenced by various drugs, foods, and beverages. Understanding these interactions and adopting strategies such as timing of administration and using alternative formulations can help optimize the therapeutic outcomes of levothyroxine treatment. Further research is needed to provide more robust evidence on these interactions and their management.
Sources and full results
Most relevant research papers on this topic
Levothyroxine Interactions with Food and Dietary Supplements–A Systematic Review
Levothyroxine ingestion in the morning and at bedtime is equally effective, but interactions with coffee, soy products, fiber, calcium, or iron supplements can decrease its absorption.
Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception
Levothyroxine treatment in euthyroid women with thyroid peroxidase antibodies did not result in a higher rate of live births compared to placebo.
REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine.
Levothyroxine alone remains the treatment of choice for hypothyroidism replacement therapy until clear advantages of levothyroxine plus liothyronine are demonstrated.
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma.
Chronic levothyroxine intake may correlate with worse outcomes and response to first-line treatments in metastatic colorectal cancer patients.
Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effects.
Bariatric surgery may compromise levothyroxine absorption or decrease dose requirements, requiring close monitoring of thyroid hormone levels.
DOI